Clinical Trial Update: Clinical Pathway Based on Procalcitonin Levels for the Management of Community-acquired Pneumonia in Outpatients [Phase 4]

View source ↗

Summary

Clinical trial update describing a procalcitonin-guided clinical pathway for outpatient management of community-acquired pneumonia (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Snippet

Sponsor: Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana | Conditions: Community-acquired Pneumonia | Phase 4 | Status: UNKNOWN